BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 23689288)

  • 1. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy.
    Al Sbihi A; Manasrah N; Sano D; Lonardo S
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33879463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of capillary electrophoresis and next-generation sequencing in the detection of immunoglobulin heavy chain H and light chain κ gene rearrangements in the diagnosis of classic hodgkin's lymphoma.
    Zhang JJ; Xie YX; Luo LL; Yang XT; Wang YX; Cao Y; Long ZB; Wang WP
    Bioengineered; 2022 Mar; 13(3):5868-5879. PubMed ID: 35220891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of gene rearrangement and lymphoma diagnosis: A prospective observational study.
    He X; Xu P; Wang X; Jiang S; Gong D; Wu N
    Medicine (Baltimore); 2020 Jun; 99(24):e20733. PubMed ID: 32541525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
    Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
    Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of detecting immunoglobulin gene rearrangements in the diagnosis of B-cell lymphoma.
    Lu C; He Q; Zhu W; Fu C; Zhou J; Tao Y; Liu S; Xiao D
    Oncotarget; 2017 Sep; 8(44):77009-77019. PubMed ID: 29100365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis.
    Libra M; De Re V; Gloghini A; Navolanic PM; Carbone A; Boiocchi M
    Leuk Lymphoma; 2004 Aug; 45(8):1539-43. PubMed ID: 15370204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma.
    Roug AS; Wendtland P; Bendix K; Kjeldsen E
    Cytogenet Genome Res; 2014; 142(1):7-13. PubMed ID: 24217199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
    Kojima M; Nakamura N; Yabe M; Tokunaka M; Kikuti YY; Kikuchi T; Murayama H; Moriuchi M; Tsuboi K; Ogawa Y; Ando K
    Int J Hematol; 2015 May; 101(5):520-4. PubMed ID: 25555480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2 Genetically distinct Burkitt lymphomas (2 primaries rather than recurrent disease): consider X-linked lymphoproliferative disorder.
    Schafernak KT
    J Pediatr Hematol Oncol; 2015 May; 37(4):330-1. PubMed ID: 25811749
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation.
    Campana S; Corradini P; Astolfi M; Ladetto M; Cinque F; Novero D; Tarella C; Pileri A
    Bone Marrow Transplant; 1997 Aug; 20(4):341-3. PubMed ID: 9285551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Burkitt lymphoma in a retinoblastoma patient with 13q deletion syndrome.
    Hongeng S; Parapakpenjun S; Pakakasama S; Rerkamnuaychoke B; Pornkul R
    Pediatr Blood Cancer; 2006 Apr; 46(4):524-6. PubMed ID: 15926151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachronous/concomitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions.
    Wei Q; Sebastian S; Papavassiliou P; Rehder C; Wang E
    Hum Pathol; 2014 Oct; 45(10):2063-76. PubMed ID: 25179408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of immunoglobulin heavy chain rearrangement in a child with recurrent Burkitt lymphoma to determine clonality.
    Nguyen JT; Kini AR; Li Y; Sarvida ME; Manera R
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e125-7. PubMed ID: 23689288
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.